A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
NCT06120751
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Tetanus
Interventions
BIOLOGICAL:
TTVA
BIOLOGICAL:
TT
Sponsor
CanSino Biologics Inc.